Business Description
Founded in 2020 and headquartered in Suwon-si, South Korea, IMBiologics Corp. is a biotechnology company focused on creating antibody-based treatments for autoimmune conditions and cancer. The company has built a portfolio of drug candidates that work by precisely adjusting the body's immune responses, targeting specific proteins involved in disease. Its pipeline includes therapies designed to address a range of conditions, from inflammatory diseases driven by overactive immune activity to tumors that attempt to hide from the immune system.
